These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24336056)

  • 1. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.
    Loo JD; Conklin L; Fleming-Dutra KE; Deloria Knoll M; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S140-51. PubMed ID: 24336056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.
    Loo JD; Conklin L; Fleming-Dutra KE; Knoll MD; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S161-71. PubMed ID: 24336058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.
    Conklin L; Loo JD; Kirk J; Fleming-Dutra KE; Deloria Knoll M; Park DE; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S109-18. PubMed ID: 24336053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
    Fleming-Dutra KE; Conklin L; Loo JD; Knoll MD; Park DE; Kirk J; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-60. PubMed ID: 24336057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.
    Reyburn R; Tsatsaronis A; von Mollendorf C; Mulholland K; Russell FM;
    J Glob Health; 2023 Feb; 13():05002. PubMed ID: 36734192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.
    Whitney CG; Goldblatt D; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S172-81. PubMed ID: 24336059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.
    Black SB; Shinefield HR; Ling S; Hansen J; Fireman B; Spring D; Noyes J; Lewis E; Ray P; Lee J; Hackell J
    Pediatr Infect Dis J; 2002 Sep; 21(9):810-5. PubMed ID: 12352800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.
    Deloria Knoll M; Park DE; Johnson TS; Chandir S; Nonyane BA; Conklin L; Fleming-Dutra KE; Loo JD; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S119-29. PubMed ID: 24336054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
    Oosterhuis-Kafeja F; Beutels P; Van Damme P
    Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.
    Park DE; Johnson TS; Nonyane BA; Chandir S; Conklin L; Fleming-Dutra KE; Loo JD; Goldblatt D; Whitney CG; O'Brien KL; Deloria Knoll M
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S130-9. PubMed ID: 24336055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial.
    Madhi SA; Mutsaerts EA; Izu A; Boyce W; Bhikha S; Ikulinda BT; Jose L; Koen A; Nana AJ; Moultrie A; Roalfe L; Hunt A; Goldblatt D; Cutland CL; Dorfman JR
    Lancet Infect Dis; 2020 Dec; 20(12):1426-1436. PubMed ID: 32857992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.
    Oligbu G; Hsia Y; Folgori L; Collins S; Ladhani S
    Vaccine; 2016 Dec; 34(50):6126-6132. PubMed ID: 27838066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule.
    Fritzell B; Fletcher MA
    Expert Rev Vaccines; 2011 Mar; 10(3):263-90. PubMed ID: 21434795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-specific Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-serotype Streptococcus pneumoniae Colonization in Children.
    Lewnard JA; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2020 Nov; 71(8):e289-e300. PubMed ID: 31784753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.
    Su WJ; Lo HY; Chang CH; Chang LY; Chiu CH; Lee PI; Lu CY; Hsieh YC; Lai MS; Lin TY
    Pediatr Infect Dis J; 2016 Apr; 35(4):e124-33. PubMed ID: 26974752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
    van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
    JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.